The global Pharmaceutical Contract Manufacturing Market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, registering a CAGR of 10.4% from 2026 to 2033. North America accounted for the largest market share of 38.44% in 2025, supported by a mature pharmaceutical ecosystem, robust R&D investments, and...

  1,2-Diphenyl Ethandione, commonly known as benzil, is an organic compound with the molecular formula C₁₄H₁₀O₂, characterized by two ketone groups attached to two phenyl rings. It presents as a yellow crystalline solid and has earned a well-established position in the fine chemicals industry owing to its versatile reactivity. Benzil is widely employed as a photoinitiator in UV-curable...

The long-term development trajectory of the global Adenosine Deaminase Deficiency Therapeutic Market is being defined by substantial clinical evolution and evolving public healthcare policies. Severe combined immunodeficiency caused by ADA mutations requires immediate, highly coordinated clinical management to prevent catastrophic systemic infections. In response, global regulatory authorities...

According to a newly published market research report by 24LifeSciences, global biomonitoring and bioburden testing market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2031. Biomonitoring involves the measurement of toxic substances in biological specimens, while...

The global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....

The Affinity Chromatography Market is witnessing significant shifts in market share as key players innovate and adapt to the growing demands of the biopharmaceutical industry. With the market size expected to rise from USD 4.953 billion in 2024 to USD 8.909 billion by 2035, the dynamics of market share are evolving rapidly. A CAGR of 5.48% underscores this growth, indicating a robust...

The Monoclonal Antibody Therapy Market is on a trajectory toward unprecedented growth, with projections indicating a market size of USD 232.1 billion by 2035. This significant escalation represents a compound annual growth rate (CAGR) of 3.97% from a current size of USD 151.25 billion in 2024. With increasing investments in biotechnology and personalized medicine, the focus on monoclonal...

Global (S)-3-Chloromandelic acid market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 51.7 million by 2034, exhibiting a CAGR of 6.2% during the forecast period. (S)-3-Chloromandelic acid is a chiral alpha-hydroxy acid characterized by the molecular formula C8H7ClO3, featuring a chlorine substituent at the meta position of the...

Global (S)-3-Methoxy-1-phenylethylamine (CAS 82796-69-8) market was valued at USD 28.4 million in 2025 and is projected to grow from USD 30.1 million in 2026 to USD 54.7 million by 2034, exhibiting a steady CAGR of 6.9% during the forecast period. (S)-3-Methoxy-1-phenylethylamine is a chiral phenethylamine derivative characterized by a methoxy substituent at the meta position of the phenyl ring...

According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...